BioSpace News Archive

NanoCellect Biomedical Inc., a leader in the development and manufacture of solutions for cell-based assays, today announced a collaboration with the Parnassus Flow Cytometry Core facility at the University of California, San Francisco (UCSF).

To protect Canadian patients from the rare but serious risk of breast implant-associated anaplastic large cell lymphoma, Health Canada is advising Allergan that the Department intends to suspend its licences for Biocell breast implants as a precautionary measure.

The U.S. Food and Drug Administration and the U.S. Customs and Border Protection leaders signed an agreement to maximize inspection and detection capabilities in order to prevent illegal and harmful products entering the U.S. through the nation’s International Mail Facilities and Ports of Entry that pose a threat to public health.

New safes for controlled substances will help combat opioid epidemic in the state and reduce robbery incidents

This week, the National CMV Foundation nominated congenital cytomegalovirus for inclusion on the Recommended Uniform Screening Panel, a list of 61 conditions the Secretary of Health and Human Services recommends states include in newborn screening panels.

In recognition of the continued collaboration and performance resulting in improved outcomes provided to Maryland’s Medicaid beneficiaries, the Maryland Department of Health has extended two contracts with Telligen.

The Cancer Support Community will present Incyte with the Founders Award for Innovation at its signature event slated for Tuesday, April 16 at The Lighthouse on Pier 61, part of the acclaimed Chelsea Piers complex on New York City’s Hudson River waterfront.

Since we announced our investigation of impurities found in drugs known as angiotensin II receptor blockers, used to treat high blood pressure and heart failure, we’ve been working to thoroughly understand how this issue arose, how we could address and mitigate exposure to this unnecessary risk to patients, and what we could do to prevent these types of impurities from reoccurring in future medications.

Circuit Clinical™ is proud to announce the addition of Andrew Brooks, Ph.D. to the Empirican Group Inc. Board of Directors

New research recently published in the Journal of Pediatric Surgery found that post-operative success rates of pediatric thyroid patients, particularly children who require a thyroidectomy, correlate with the institution’s patient volume.